|
MELBOURNE, Australia, Nov. 20, 2025 /PRNewswire/ -- Sungrow, the global leading PV inverter and energy storage system provider, proudly strengthened its long-standing strategic alliances with top renewable energy distributors, Raystech Group, Supply Partners, and Tradezone during a formal signing ceremony at the 2025 All-Energy Australia exhibition. These enhanced signings mark a pivotal milestone in Sungrow's continued dedication to accelerating Australia's clean energy transition through trusted partnerships and innovative solutions.
Three Key Partners Sign 2026 Distribution Agreements
- The Agreement with Prominent Wholesale Distributor in Australia and New Zealand – Raystech Group
Building on a successful partnership, Sungrow has entered a new distribution agreement with Raystech Group, a leading renewable energy wholesaler headquartered in Brisbane. Under the 2026 agreement, Raystech will deliver 800MW of Sungrow PV inverters, including 450MW for residential, 150MW for commercial & industrial (C&I), and 200MW for utility-scale applications.
In addition, Raystech will supply 1GWh of Sungrow battery energy storage systems (BESS) in 2026, including 600MWh for residential, 150MWh for C&I, and 250MWh for utility-scale projects. This collaboration reinforces Sungrow's commitment to accelerating the clean energy transition and expanding access to advanced solar and storage solutions across Australia and New Zealand.
- The Expanded Agreement with Long-Standing Partner in Australia's Renewable Energy Sector – Supply Partners
At All-Energy Australia 2025, Sungrow and Supply Partners renewed their strategic distribution agreement for 2026, covering 300MW of PV inverters and 300MWh of residential battery energy storage systems (BESS).
Supply Partners will continue to lead direct distribution across residential, commercial, and battery segments, reinforcing a shared commitment to delivering reliable and future-ready clean energy solutions for Australia's evolving market.
- The Strategic Agreement with Australia's Largest Online Electrical Wholesaler Tradezone
Sungrow and Tradezone formalised a strategic partnership to deliver trusted clean energy solutions to communities nationwide. By strengthening supply channels and empowering thousands of installers, this collaboration brings smarter solar and storage technologies to more Australian households and businesses, accelerating the transition to a sustainable energy future.
About Raystech
Raystech is an international brand in leading renewable energy wholesale distribution with a footprint all across Australia and New Zealand. In Australia and New Zealand, self-operated sales offices and widest warehouses across Australia and distribution centers in major cities provide a comprehensive solar solution to their clients. Raystech shares synergy with their clients and suppliers aimed to become an industry-preferred renewable energy wholesale distributor in a customer-centric business model.
About Supply Partners
Established in 2012, Supply Partners is a highly trusted distributor in Australia's renewable energy sector, specialising in the distribution of premium solar and storage solutions. With a strong focus on residential, commercial, and battery segments, the company delivers tailored support and technical expertise to installers nationwide. Supply Partners is known for its customer-first approach, streamlined logistics, and commitment to advancing clean energy adoption across Australia.
About Tradezone
Tradezone is Australia's largest local electrical supplier, proudly family-owned and operated for over 30 years. Renowned as the go-to source for electrical supply needs, Tradezone serves electricians, tradies, and industry professionals across Sydney, Newcastle, Rural New South Wales, and Canberra. With an extensive inventory includes everything from premium solar panels to industrial electrical supplies, Tradezone combines deep industry expertise with reliable service to power Australia's clean energy future.
About Sungrow
Sungrow, a global leader in renewable energy technology, has pioneered sustainable power solutions for over 28 years. As of June 2025, Sungrow has installed 870 GW of power electronic converters worldwide. The Company is recognized as the world's most bankable PV inverter and energy storage company (BloombergNEF). Its innovations power clean energy projects across the globe, supported by a network of 520 service outlets guaranteeing excellent customer experience. At Sungrow, we're committed to bridging to a sustainable future through cutting-edge technology and unparalleled service. For more information, please visit: www.sungrowpower.com.
MELBOURNE, Australia, Nov. 20, 2025 /PRNewswire/ -- Sungrow, the global leading PV inverter and energy storage system provider, proudly strengthened its long-standing strategic alliances with top renewable energy distributors, Raystech Group, Supply Partners, and Tradezone during a formal signing ceremony at the 2025 All-Energy Australia exhibition. These enhanced signings mark a pivotal milestone in Sungrow's continued dedication to accelerating Australia's clean energy transition through trusted partnerships and innovative solutions.
Three Key Partners Sign 2026 Distribution Agreements
- The Agreement with Prominent Wholesale Distributor in Australia and New Zealand – Raystech Group
Building on a successful partnership, Sungrow has entered a new distribution agreement with Raystech Group, a leading renewable energy wholesaler headquartered in Brisbane. Under the 2026 agreement, Raystech will deliver 800MW of Sungrow PV inverters, including 450MW for residential, 150MW for commercial & industrial (C&I), and 200MW for utility-scale applications.
In addition, Raystech will supply 1GWh of Sungrow battery energy storage systems (BESS) in 2026, including 600MWh for residential, 150MWh for C&I, and 250MWh for utility-scale projects. This collaboration reinforces Sungrow's commitment to accelerating the clean energy transition and expanding access to advanced solar and storage solutions across Australia and New Zealand.
- The Expanded Agreement with Long-Standing Partner in Australia's Renewable Energy Sector – Supply Partners
At All-Energy Australia 2025, Sungrow and Supply Partners renewed their strategic distribution agreement for 2026, covering 300MW of PV inverters and 300MWh of residential battery energy storage systems (BESS).
Supply Partners will continue to lead direct distribution across residential, commercial, and battery segments, reinforcing a shared commitment to delivering reliable and future-ready clean energy solutions for Australia's evolving market.
- The Strategic Agreement with Australia's Largest Online Electrical Wholesaler Tradezone
Sungrow and Tradezone formalised a strategic partnership to deliver trusted clean energy solutions to communities nationwide. By strengthening supply channels and empowering thousands of installers, this collaboration brings smarter solar and storage technologies to more Australian households and businesses, accelerating the transition to a sustainable energy future.
About Raystech
Raystech is an international brand in leading renewable energy wholesale distribution with a footprint all across Australia and New Zealand. In Australia and New Zealand, self-operated sales offices and widest warehouses across Australia and distribution centers in major cities provide a comprehensive solar solution to their clients. Raystech shares synergy with their clients and suppliers aimed to become an industry-preferred renewable energy wholesale distributor in a customer-centric business model.
About Supply Partners
Established in 2012, Supply Partners is a highly trusted distributor in Australia's renewable energy sector, specialising in the distribution of premium solar and storage solutions. With a strong focus on residential, commercial, and battery segments, the company delivers tailored support and technical expertise to installers nationwide. Supply Partners is known for its customer-first approach, streamlined logistics, and commitment to advancing clean energy adoption across Australia.
About Tradezone
Tradezone is Australia's largest local electrical supplier, proudly family-owned and operated for over 30 years. Renowned as the go-to source for electrical supply needs, Tradezone serves electricians, tradies, and industry professionals across Sydney, Newcastle, Rural New South Wales, and Canberra. With an extensive inventory includes everything from premium solar panels to industrial electrical supplies, Tradezone combines deep industry expertise with reliable service to power Australia's clean energy future.
About Sungrow
Sungrow, a global leader in renewable energy technology, has pioneered sustainable power solutions for over 28 years. As of June 2025, Sungrow has installed 870 GW of power electronic converters worldwide. The Company is recognized as the world's most bankable PV inverter and energy storage company (BloombergNEF). Its innovations power clean energy projects across the globe, supported by a network of 520 service outlets guaranteeing excellent customer experience. At Sungrow, we're committed to bridging to a sustainable future through cutting-edge technology and unparalleled service. For more information, please visit: www.sungrowpower.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Sungrow Elevates Australian Renewable Energy Alliances: Three Key Partners Ink 2026 Distribution Agreements
|
The National University Centre for Digestive Health heralds a new era of care through quicker cross-referrals to surgical specialties, strengthened community partnerships and patient-friendly treatment delivery
SINGAPORE, Jan. 16, 2026 /PRNewswire/ -- Digestive health is central to overall well-being, influencing nutrition, immunity, and quality of life. Yet common conditions, such as ulcers, liver disease, and colorectal disorders, often go undetected until they lead to serious complications. To address this, the National University Hospital (NUH) has officially opened the National University Centre for Digestive Health (NUCD), a facility dedicated to early detection, advanced treatment, and seamless patient care for digestive diseases.
Since its concept launch in 2024, NUCD has focused on consolidating NUH's digestive health services under one roof to provide greater convenience for patients. Its reach extends beyond NUH, serving as a referral hub for complex cases from other hospitals within the National University Health System, including Ng Teng Fong General Hospital and Alexandra Hospital, ensuring patients receive specialised care when needed.
With its official opening, the Centre is strengthening the entire care pathway by accelerating access from initial digestive consultation to surgical expertise in Upper Gastrointestinal, Hepatobiliary and Pancreatic, and Colorectal, so patients can see the right specialists on the same day. This streamlined approach reduces waiting times, minimises repeated visits, and enables faster treatment decisions for better outcomes.
Strengthening prevention: From community collaborations to clinical excellence
NUCD has contributed significantly to the clinical validation and implementation of the Fibrosis-4 (FIB-4) score and fibroscan to screen for liver fibrosis, or scarring of the liver, in high-risk patients with fatty liver and other chronic liver diseases[1]. Since September 2022, a chronic liver disease screening programme for high-risk individuals has been launched in partnership with National University Polyclinics and General Practitioners (GP) clinics. Through consultations and routine health assessments done at these clinics, asymptomatic individuals identified as potentially high-risk are referred to NUCD for comprehensive screening. To date, the Centre has screened more than 12,000 high-risk patients, facilitating earlier detection and interventions. With continuing medical education and engagement, NUCD continues to expand this network to enhance preventive care for liver health.
Another key focus of the Centre is improving the detection of colorectal cancer, often called a 'silent killer' because symptoms usually appear only in later stages. According to the Singapore Cancer Registry Annual Report 2022[2], colorectal cancer is the second most common cancer and the second leading cause of cancer-related deaths locally. To tackle this, the Centre is improving colonoscopy quality by increasing the Adenoma Detection Rate (ADR), a measure of how often doctors detect and remove precancerous polyps during the procedure.
Studies[3] show that every 1 per cent increase in ADR lowers colorectal cancer risk by 3 per cent, making these improvements a vital step in prevention. Put simply, a higher ADR means that more polyps are removed early, reducing cancer risk. New initiatives such as AI-enabled and image-enhanced colonoscopy, an automated ADR calculation system, and a dashboard displaying critical quality indicators for endoscopists have helped boost ADR at NUCD from 33.5 per cent in 2022 to 42.4 per cent in 2025, well above the American Society for Gastrointestinal Endoscopy guideline of at least 25 per cent[4].
Making IBD care more convenient and precise
Established in 2016, the Inflammatory Bowel Disease (IBD) Centre of Excellence is now a cornerstone of NUCD, delivering advanced care across all ages - from paediatric to adult patients. Among its key innovations is the home administration of intravenous biologics, reducing the need for frequent hospital visits and improving convenience.
Others include point-of-care intestinal ultrasound, which enables real-time, non-invasive assessment during clinic consultations, and a translational precision medicine programme that personalises treatment and provides access to clinical trials and novel therapies, such as faecal microbiota transplantation. The IBD Centre of Excellence also aims to play a leading role in regional education, having hosted IBD training programmes for over 100 healthcare professionals from ASEAN countries in the past five years.
"The launch of NUCD marks a significant step forward in how we care for patients with digestive conditions," said Adj A/Prof Lee Guan Huei, Centre Director, National University Centre for Digestive Health. "By bringing together advanced diagnostics, specialist expertise, and cutting-edge technology, we aim to deliver care that is faster, more precise, and patient-focused. At the same time, we are driving research into new detection methods and innovative therapies, such as blood-based diagnostic tools that reduce the need for invasive procedures while maintaining accuracy. Our goal is simple - to detect problems early, treat them well, and help our patients live healthier lives." Adj A/Prof Lee is also Head and Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, NUH.
About the National University Hospital (NUH)
The National University Hospital (NUH) is Singapore's leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.
Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.
We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.
The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore. For more information, visit www.nuh.com.sg
Follow us on
Facebook | Instagram | LinkedIn | TikTok | YouTube
| [1] Chew NWS, Ng CH, Chan KE, et al. FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease. Can J Cardiol 2022 Nov;38(11):1779-1780. |
| [2] Singapore Cancer Registry Annual Report 2022, September 2024, https://www.nrdo.gov.sg/publications/cancer |
| [3] Corley DA, Levin TR, Doubeni CA.Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:2541. |
| [4] Song YM, Han KS, Kim BC, Hong CW, Kim B, Kim MC, Jin MJ, Sohn DK. Analysis of adenoma detection rate of colonoscopy among trainees. Ann Coloproctol. 2024 Dec;40(6):548-554. doi: 10.3393/ac.2023.00199.0028. Epub 2024 Aug 28. PMID: 39191316; PMCID: PMC11701454. |
The National University Centre for Digestive Health heralds a new era of care through quicker cross-referrals to surgical specialties, strengthened community partnerships and patient-friendly treatment delivery
SINGAPORE, Jan. 16, 2026 /PRNewswire/ -- Digestive health is central to overall well-being, influencing nutrition, immunity, and quality of life. Yet common conditions, such as ulcers, liver disease, and colorectal disorders, often go undetected until they lead to serious complications. To address this, the National University Hospital (NUH) has officially opened the National University Centre for Digestive Health (NUCD), a facility dedicated to early detection, advanced treatment, and seamless patient care for digestive diseases.
Since its concept launch in 2024, NUCD has focused on consolidating NUH's digestive health services under one roof to provide greater convenience for patients. Its reach extends beyond NUH, serving as a referral hub for complex cases from other hospitals within the National University Health System, including Ng Teng Fong General Hospital and Alexandra Hospital, ensuring patients receive specialised care when needed.
With its official opening, the Centre is strengthening the entire care pathway by accelerating access from initial digestive consultation to surgical expertise in Upper Gastrointestinal, Hepatobiliary and Pancreatic, and Colorectal, so patients can see the right specialists on the same day. This streamlined approach reduces waiting times, minimises repeated visits, and enables faster treatment decisions for better outcomes.
Strengthening prevention: From community collaborations to clinical excellence
NUCD has contributed significantly to the clinical validation and implementation of the Fibrosis-4 (FIB-4) score and fibroscan to screen for liver fibrosis, or scarring of the liver, in high-risk patients with fatty liver and other chronic liver diseases[1]. Since September 2022, a chronic liver disease screening programme for high-risk individuals has been launched in partnership with National University Polyclinics and General Practitioners (GP) clinics. Through consultations and routine health assessments done at these clinics, asymptomatic individuals identified as potentially high-risk are referred to NUCD for comprehensive screening. To date, the Centre has screened more than 12,000 high-risk patients, facilitating earlier detection and interventions. With continuing medical education and engagement, NUCD continues to expand this network to enhance preventive care for liver health.
Another key focus of the Centre is improving the detection of colorectal cancer, often called a 'silent killer' because symptoms usually appear only in later stages. According to the Singapore Cancer Registry Annual Report 2022[2], colorectal cancer is the second most common cancer and the second leading cause of cancer-related deaths locally. To tackle this, the Centre is improving colonoscopy quality by increasing the Adenoma Detection Rate (ADR), a measure of how often doctors detect and remove precancerous polyps during the procedure.
Studies[3] show that every 1 per cent increase in ADR lowers colorectal cancer risk by 3 per cent, making these improvements a vital step in prevention. Put simply, a higher ADR means that more polyps are removed early, reducing cancer risk. New initiatives such as AI-enabled and image-enhanced colonoscopy, an automated ADR calculation system, and a dashboard displaying critical quality indicators for endoscopists have helped boost ADR at NUCD from 33.5 per cent in 2022 to 42.4 per cent in 2025, well above the American Society for Gastrointestinal Endoscopy guideline of at least 25 per cent[4].
Making IBD care more convenient and precise
Established in 2016, the Inflammatory Bowel Disease (IBD) Centre of Excellence is now a cornerstone of NUCD, delivering advanced care across all ages - from paediatric to adult patients. Among its key innovations is the home administration of intravenous biologics, reducing the need for frequent hospital visits and improving convenience.
Others include point-of-care intestinal ultrasound, which enables real-time, non-invasive assessment during clinic consultations, and a translational precision medicine programme that personalises treatment and provides access to clinical trials and novel therapies, such as faecal microbiota transplantation. The IBD Centre of Excellence also aims to play a leading role in regional education, having hosted IBD training programmes for over 100 healthcare professionals from ASEAN countries in the past five years.
"The launch of NUCD marks a significant step forward in how we care for patients with digestive conditions," said Adj A/Prof Lee Guan Huei, Centre Director, National University Centre for Digestive Health. "By bringing together advanced diagnostics, specialist expertise, and cutting-edge technology, we aim to deliver care that is faster, more precise, and patient-focused. At the same time, we are driving research into new detection methods and innovative therapies, such as blood-based diagnostic tools that reduce the need for invasive procedures while maintaining accuracy. Our goal is simple - to detect problems early, treat them well, and help our patients live healthier lives." Adj A/Prof Lee is also Head and Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine, NUH.
About the National University Hospital (NUH)
The National University Hospital (NUH) is Singapore's leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.
Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.
We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.
The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore. For more information, visit www.nuh.com.sg
Follow us on
Facebook | Instagram | LinkedIn | TikTok | YouTube
[1] Chew NWS, Ng CH, Chan KE, et al. FIB-4 Predicts MACE and Cardiovascular Mortality in Patients With Nonalcoholic Fatty Liver Disease. Can J Cardiol 2022 Nov;38(11):1779-1780.
[2] Singapore Cancer Registry Annual Report 2022, September 2024, https://www.nrdo.gov.sg/publications/cancer
[3] Corley DA, Levin TR, Doubeni CA.Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:2541.
[4] Song YM, Han KS, Kim BC, Hong CW, Kim B, Kim MC, Jin MJ, Sohn DK. Analysis of adenoma detection rate of colonoscopy among trainees. Ann Coloproctol. 2024 Dec;40(6):548-554. doi: 10.3393/ac.2023.00199.0028. Epub 2024 Aug 28. PMID: 39191316; PMCID: PMC11701454.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
NUH INAUGURATES NEW CENTRE TO ADVANCE PREDICTIVE AND ACCESSIBLE CARE FOR DIGESTIVE HEALTH
